Authors


Sally Grosvenor

Latest:

A New Era in Cell Culture Media Development

Cell-line specific complex media supplements combine chemically defined media additives into a single supplement.



Mark Blanchard

Latest:

Considerations for Scaling-up Depth Filtration of Harvested Cell Culture Fluid

Data on the performance and variability of different formats.


Marc Scholtyssek

Latest:

Fusion Tags for Protein Expression and Purification

Gene fusion tags can improve the yield and solubility of many recombinant proteins. This article discusses the most popular fusion tags and the proteases used to remove them, with special reference to recently introduced technologies.


Borka Naumovich

Latest:

Improving Protein Production in CHO Cells

Using chemically defined feeds with CHO cell lines not only eliminates the variability associated with using plant hydrolysates, but could also improve the productivity of biopharmaceutical protein manufacture and help move therapeutic proteins into clinical trials more rapidly.


Matthew Kopecky

Latest:

How to Avert Supply-Chain Quality Failures

To stave off quality issues associated with production processes, a centralized and enterprise-wide quality management initiative must be enforced.


Barak I. Barnoon

Latest:

Lifecycle Cost Analysis for Single-Use Systems

This article describes a quick method for evaluating lifecycle costs for single-use systems against their more conventional stainless-steel counterparts.


Alejandro Portillo

Latest:

Manufacturing Process Development for an Epidermal Growth Factor-Based Cancer Vaccine

The Center for Molecular Immunology (Havana, Cuba) has been working on a novel cancer immunotherapy targeting the epidermal growth factor (EGF). The vaccine is composed of a chemical conjugate of EGF and a carrier protein (rP64k), designed to trigger an anti-EGF antibody response. The results of studies of molecular characterization, immunogenic activity, and clinical data are presented here.



Leonardo Giovannoni, PhD

Latest:

Antibody Purification Using Membrane Adsorbers

A membrane adsorber in retention mode can be used efficiently in a commercial antibody manufacturing process.



Sophie Nallet

Latest:

Recombinant Protein Production Yields from Mammalian Cells: Past, Present, and Future

A discussion of past achievements and future expectations of recombinant protein production yields from mammalian cells.



David (Xiaojian) Zhao

Latest:

Improving Protein Production in CHO Cells

Using chemically defined feeds with CHO cell lines not only eliminates the variability associated with using plant hydrolysates, but could also improve the productivity of biopharmaceutical protein manufacture and help move therapeutic proteins into clinical trials more rapidly.


Charles Siletti, PhD

Latest:

Systematic Evaluation of Single-Use Systems Using Process Simulation Tools

This article describes the steps required to build a comprehensive model in a batch process simulator for a process that uses single-use systems for buffer preparation and storage.


Timothy Hagerty

Latest:

The Development and Application of a Monoclonal Antibody Purification Platform

A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.


Agilent Technologies, Inc.

Latest:

Intact Mass Analysis of Multispecific Antibodies: Automation and Data Management

Tuesday, October 25th, 2022 at 11am EDT|8am PDT|4pm BST|5pm CEST Discover approaches for medium- and high-throughput analysis of multispecific antibodies using Byos software with AWS automation workflows. In this presentation, we will discuss how to use this data to select optimal therapeutic candidates produced on our high-throughput protein production platform.


Florian M. Wurm, PhD

Latest:

Recombinant Protein Production Yields from Mammalian Cells: Past, Present, and Future

A discussion of past achievements and future expectations of recombinant protein production yields from mammalian cells.


Onur Unal

Latest:

Fusion Tags for Protein Expression and Purification

Gene fusion tags can improve the yield and solubility of many recombinant proteins. This article discusses the most popular fusion tags and the proteases used to remove them, with special reference to recently introduced technologies.




Chantal Déziel

Latest:

Considerations When Outsourcing the Production of Clinical Material

It is important to understand critical aspects of the CMO's capabilities. Only by auditing certain key areas can the sponsor be assured of the quality of the materials produced.


Reuben Lidster

Latest:

A Case Study of Developing Analytical Methods

Contract manufacturers must plan for increased analytical resources in development and quality control.


Ariadna Cuevas

Latest:

Manufacturing Process Development for an Epidermal Growth Factor-Based Cancer Vaccine

The Center for Molecular Immunology (Havana, Cuba) has been working on a novel cancer immunotherapy targeting the epidermal growth factor (EGF). The vaccine is composed of a chemical conjugate of EGF and a carrier protein (rP64k), designed to trigger an anti-EGF antibody response. The results of studies of molecular characterization, immunogenic activity, and clinical data are presented here.


Derek Ellison, Ph.D.

Latest:

Developing the Future: Big Questions, Multiple Answers

When you don't know the answer to a question, ask an expert. If the question is really big, ask more experts. If you have a collection of difficult questions, run a poll of many experts. That, in effect, was the impetus for Eden Biodesign to survey 670 BioPharm International subscribers with questions as to what will be the development mechanism to achieve safe, effective, and cheap new medicines.


Lisel Viña

Latest:

Manufacturing Process Development for an Epidermal Growth Factor-Based Cancer Vaccine

The Center for Molecular Immunology (Havana, Cuba) has been working on a novel cancer immunotherapy targeting the epidermal growth factor (EGF). The vaccine is composed of a chemical conjugate of EGF and a carrier protein (rP64k), designed to trigger an anti-EGF antibody response. The results of studies of molecular characterization, immunogenic activity, and clinical data are presented here.


David L. Hacker, PhD

Latest:

Recombinant Protein Production Yields from Mammalian Cells: Past, Present, and Future

A discussion of past achievements and future expectations of recombinant protein production yields from mammalian cells.


Kelli Watson Francuzenko

Latest:

Top 10 Legal Issues Biotech Start-Ups Must Address

A top-10 list of critical legal issues that biotech start-ups should make an effort to address, even when the capital squeeze is intense.


Victor Papavasileiou

Latest:

Systematic Evaluation of Single-Use Systems Using Process Simulation Tools

This article describes the steps required to build a comprehensive model in a batch process simulator for a process that uses single-use systems for buffer preparation and storage.


Gisela Gonzalez

Latest:

Manufacturing Process Development for an Epidermal Growth Factor-Based Cancer Vaccine

The Center for Molecular Immunology (Havana, Cuba) has been working on a novel cancer immunotherapy targeting the epidermal growth factor (EGF). The vaccine is composed of a chemical conjugate of EGF and a carrier protein (rP64k), designed to trigger an anti-EGF antibody response. The results of studies of molecular characterization, immunogenic activity, and clinical data are presented here.

© 2024 MJH Life Sciences

All rights reserved.